[Expression of macrophage colony stimulating factor in brains of PDAPPV717I transgenic mice]

Jian-min Zhang1, Qing-li Kong, Hong Wang

  • 1Department of Immunology, Institute of Basic Medical Sciences, CAMS and PUMC, Beijing 100005, China.

Abstract

Insights

Reactive astrocytes in Alzheimer's disease models produce more macrophage colony-stimulating factor (M-CSF). This suggests astrocytes are key in the neuropathology of Alzheimer's disease.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pathology

Context:

  • Alzheimer's disease (AD) is a progressive neurodegenerative disorder.
  • Amyloid precursor protein (APP) mutations are linked to familial AD.
  • PDAPPV717I transgenic mice model key aspects of AD neuropathology.

Purpose:

  • To investigate the expression and localization of macrophage colony-stimulating factor (M-CSF) in the brains of PDAPPV717I transgenic mice.
  • To determine the cellular source of M-CSF in the context of AD-like pathology.

Summary:

  • Macrophage colony-stimulating factor (M-CSF) mRNA expression was significantly elevated in the brains of PDAPPV717I transgenic mice compared to non-transgenic controls.
  • Immunohistochemical and in situ hybridization analyses revealed that M-CSF mRNA is predominantly produced by reactive astrocytes within the brain.
  • These findings highlight a specific molecular pathway involving astrocytes in AD pathogenesis.

Impact:

  • Astrocytes are implicated as significant contributors to the onset and progression of Alzheimer's disease neuropathology.
  • Understanding M-CSF's role in astrocytes may reveal novel therapeutic targets for Alzheimer's disease.
  • This research advances the understanding of glial cell involvement in neurodegenerative diseases.

Related Concept Videos